Healthcare

CytoDyn (OTC: CYDY) to Hold Investment Community Conference Call on December 17, 2019

VANCOUVER, Washington, Dec. 11, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Nader […]

Newsmakers

Nightfood Ice Cream (OTC: NGTF) Hotel Initiatives Underway; Product Selling Well in Initial Locations

Tarrytown, NY, Dec 11, 2019  — Nightfood, Inc. (otcqb:NGTF), the award-winning ice cream company addressing America’s $50 billion-dollar nighttime snacking market, recently announced it had hired MSourceIdeas and Mr. Lionel Binnie to spearhead major distribution […]

Newsmakers

NexTech (OTC: NEXCF) Expands AR Deal With Walther Arms Inc., Manufacturer of James Bond’s PPK

NEW YORK and TORONTO, Dec. 05, 2019 — NexTech AR Solutions (NexTech) (otcqb:NEXCF) (NTAR)(N29), the leader in augmented reality for e-commerce and AR learning applications, has expanded its relationship with Walther Arms, most famous as the manufacturer […]

Healthcare

CytoDyn (OTC: CYDY) Reports Early Results from First Patient in its Phase 1b/2 CCR5+ Metastatic Triple-Negative Breast Cancer Trial

VANCOUVER, Washington, Dec 03, 2019  — First metastatic triple-negative breast cancer patient showed no detectable circulating tumor cells (CTC) or putative metastatic tumor cells (EMTs) in the peripheral blood. Further, a significant reduction in CCR5 […]

Healthcare

Hoth Therapeutics (NASDAQ: HOTH) and North Carolina State University Enter License Agreement for Gene Therapy

Collaboration will Target a Therapeutic Approach for Treating Asthma and Allergic Diseases NEW YORK, Nov. 26, 2019– Hoth Therapeutics, Inc. (NASDAQ: HOTH), (“HOTH” or the “Company”), a biopharmaceutical company focused on developing new generation therapies for dermatological […]

Healthcare

CytoDyn (OTC: CYDY) Reports Strong Positive Preclinical Data to Demonstrate Potential of Leronlimab in Treating Nonalcoholic Fatty Liver Disease (NAFLD) in Humanized Mouse Model

New preclinical data using a humanized mouse model confirms and expands on the potential use of leronlimab in treating this inflammatory syndrome, a common precursor to NASH VANCOUVER, Washington, Nov 21, 2019 — CytoDyn Inc. […]

Newsmakers

Nightfood Ice Cream (OTC: NGTF) Obtains Distribution Commitment from Additional Top-10 Supermarket Chain

TARRYTOWN, NY, Nov. 20, 2019–  Nightfood, Inc. (otcqb:NGTF), the award-winning ice cream company addressing America’s $50 billion-dollar nighttime snacking problem, yesterday received confirmation that sleep-friendly Nightfood ice cream will soon be made available in a […]

Newsmakers

CytoDyn’s (OTC: CYDY) Lead Product Candidate Leronlimab (PRO 140) Inhibits Colon Carcinoma Metastases to Liver and Lung in Preclinical Studies

CytoDyn will file for expanded access IND for patients with pancreatic, prostate, lung, breast, liver and melanoma cancers VANCOUVER, Washington, Nov 19, 2019  — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology […]

Newsmakers

NexTechAR (OTC: NEXCF) Teams with LivePerson (NASDAQ: LPSN) to Personalize Augmented Reality Through Conversational Commerce

One-of-a-kind, transformative technology for retailers combines messaging and AR experiences NEW YORK and TORONTO, Nov 19, 2019– NEW YORK and TORONTO, Nov. 19, 2019 — NexTech AR Solutions (the “Company” or “NexTech”) (otcqb:NEXCF) (NTAR)(N29), the […]